Riskpilot← Back to searchSign inGet full accessRoseuskliniken AB
ABIn liquidationOrg 5592716228Other human health activities · NACE 8690Est. 20200 employees
Revenue 2022
SEK 0
EBITDA margin
—
-5258% vs 2021
Equity ratio
28.8%
Financial strength
Net profit 2022
SEK -321K
-5258% vs 2021
| Revenue | SEK 0 | — |
| EBITDA | SEK -321K | -5258% |
| Net profit | SEK -321K | -5258% |
| Total assets | SEK 205K | +118% |
| Equity | SEK 59K | -37% |
| Employees | 0 | — |
Legal name
Roseuskliniken AB
Org number
5592716228
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
16 september 2020
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknarna
Company purpose
Bolaget ska etablera och driva en klinik för diagnostik och behandling av främst kvinnliga cancersjukdomar jämte därtill hörande verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | −286 |
| EBITDA | −6 | −321 |
| Depreciation & amort. | −0 | — |
| EBIT | −6 | −321 |
| Net financials | — | — |
| Profit before tax | −6 | −321 |
| Tax | −0 | — |
| Net profit | −6 | −321 |
| Item | 2021 | 2022 |
|---|---|---|
| Total assets | 94 | 205 |
| Equity | 94 | 59 |
| Long-term debt | 0 | — |
| Short-term debt | 0 | 146 |
| Total debt | — | 146 |
EBITDA margin
-32145500.0%
This company
15.8%
Market median
-203452632% vs market
20212022
Equity ratio
28.8%
This company
38.2%
Market median
-25% vs market
20212022
Return on equity
-543.5%
This company
18.4%
Market median
-3054% vs market
20212022
Net profit margin
-32145500.0%
This company
8.1%
Market median
-396858125% vs market
20212022
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212022
Debt / equity
2.47×
This company
0.62×
Market median
-298% vs market
20212022
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
LB External Signatory | External Signatory | 2022 |
IM External Signatory | External Signatory | 2022 |
BJ Liquidator | Liquidator | 2022 |
UM External Signatory | External Signatory | 2022 |
| Former (1) | ||
RT Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (4) | ||
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Chairman | 2023 – 2024 | |
| Deputy Board Member | 2023 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Roseuskliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | External Signatory | 0 companies |
| Inger Margareta Dahle | External Signatory | 0 companies |
| Bengt Junior Niklas Nygårds | Liquidator | 0 companies |
| Ulrika Margareta Ahlholm | External Signatory | 0 companies |
| Ronnie Thomas Katra | Audit | 0 companies |
| Maj Boel Flodgren | Board of Directors | 0 companies |
| Lars Henrik Bruzelius | Board of Directors | 0 companies |
| Sven Christian Henschen Ingvar | Chairman | 0 companies |
| Jan Kristian Pietras | Deputy Board Member | 0 companies |